National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, and.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA.
J Clin Invest. 2021 Sep 15;131(18). doi: 10.1172/JCI149722.
BACKGROUNDCertain components of rest-activity rhythms such as greater eveningness (delayed phase), physical inactivity (blunted amplitude), and shift work (irregularity) are associated with increased risk for drug use. Dopaminergic (DA) signaling has been hypothesized to mediate the associations, though clinical evidence is lacking.METHODSWe examined associations between rhythm components and striatal D1 (D1R) and D2/3 receptor (D2/3R) availability in 32 healthy adults (12 female, 20 male; age 42.40 ± 12.22 years) and its relationship to drug reward. Rest-activity rhythms were assessed by 1-week actigraphy combined with self-reports. [11C]NNC112 and [11C]raclopride positron emission tomography (PET) scans were conducted to measure D1R and D2/3R availability, respectively. Additionally, self-reported drug-rewarding effects of 60 mg oral methylphenidate were assessed.RESULTSWe found that delayed rhythm was associated with higher D1R availability in caudate, which was not attributable to sleep loss or so-called social jet lag, whereas physical inactivity was associated with higher D2/3R availability in nucleus accumbens (NAc). Delayed rest-activity rhythm, higher caudate D1R, and NAc D2/3R availability were associated with greater sensitivity to the rewarding effects of methylphenidate.CONCLUSIONThese findings reveal specific components of rest-activity rhythms associated with striatal D1R, D2/3R availability, and drug-rewarding effects. Personalized interventions that target rest-activity rhythms may help prevent and treat substance use disorders.TRIAL REGISTRATIONClinicalTrials.gov: NCT03190954.FUNDINGNational Institute on Alcohol Abuse and Alcoholism (ZIAAA000550).
静息-活动节律的某些成分,如更大的晚型(延迟相位)、体力活动减少(幅度变平)和轮班工作(不规则),与药物使用风险增加有关。多巴胺能(DA)信号被假设为介导这些关联,尽管缺乏临床证据。
我们在 32 名健康成年人(12 名女性,20 名男性;年龄 42.40±12.22 岁)中检查了节律成分与纹状体 D1(D1R)和 D2/3 受体(D2/3R)可用性之间的关联,以及其与药物奖励的关系。静息-活动节律通过 1 周的活动记录仪与自我报告相结合进行评估。[11C]NNC112 和[11C]raclopride 正电子发射断层扫描(PET)扫描分别用于测量 D1R 和 D2/3R 的可用性。此外,还评估了 60mg 口服哌甲酯的自我报告药物奖励效应。
我们发现,延迟的节律与尾状核中的 D1R 可用性增加有关,这与睡眠不足或所谓的社交时差无关,而体力活动减少与伏隔核(NAc)中的 D2/3R 可用性增加有关。延迟的静息-活动节律、更高的尾状核 D1R 和 NAc D2/3R 可用性与哌甲酯的奖励效应的敏感性增加有关。
这些发现揭示了静息-活动节律与纹状体 D1R、D2/3R 可用性和药物奖励效应相关的特定成分。针对静息-活动节律的个性化干预措施可能有助于预防和治疗物质使用障碍。
ClinicalTrials.gov:NCT03190954。
国家酒精滥用和酒精中毒研究所(ZIAAA000550)。